mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.31 |
1e-05 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.0002 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0007 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
0.002 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
BRD-K58730230 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.003 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.004 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.005 |